赵凯;谷文光;董志伟;王健;

• 1:哈尔滨医科大学附属第一医院

摘要(Abstract)：

软组织肉瘤是一种高度异质性来源于间充质组织的恶性肿瘤。由于其组织学亚型较多,临床和组织病理学的不确定性,对于目前的诊断和治疗都是很棘手问题。其中一个重要的临床问题是缺乏有用的生物标志物;因此,可用于检测肿瘤的生物标志物的发现对化疗或放疗的反应可能有助于临床医生提供更有效的临床管理。microRNA在软组织肉瘤中研究提供了解决问题线索。软组织肉瘤中差异microRNA和患者血清中的循环microRNA等证据发现潜在的加速了向临床应用的转变,这无疑给根除软组织肉瘤带来了新的希望。

关键词(KeyWords)： MicroRNA;软组织肉瘤;生物标记物;治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 赵凯;谷文光;董志伟;王健;

Email:

DOI:

参考文献(References)：

• [1]Subramanian S,Lui WO,Lee CH,et al.Micro RNA expression signature of human sarcomas[J].Oncogene,2008,27(14):2015-2026.
• [2]Guled M,Pazzaglia L,Borze I,et al.Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma:a mi RNA analysis[J].Genes Chromosomes Cancer,2014,53(8):693-702.
• [3]Renner M,Czwan E,Hartmann W,et al.Micro RNA profiling of primary high-grade soft tissue sarcomas[J].Genes Chromosomes Cancer,2012,51(11):982-996.
• [4]Garofalo M,Jeon YJ,Nuovo GJ,et al.Correction:Mi R-34a/c-Dependent PDGFR-ery downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer[J].Plos One,2015,10(6):113-124.
• [5]Fletcher CDM.The evolving classification of soft tissue tumoursan update based on the nwe 2013 WHO classification[J].Pathology,2006,64(1):2-11.
• [6]Ugras S,Brill E,Jacobsen A,et al.Small RNA sequencing and functional characterization reveals Micro RNA-143 tumor suppressor activity in liposarcoma[J].Cancer Res,2011,71(17):5659-5669.
• [7]Taylor BS,Decarolis PL,Angeles CV,et al.Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas[J].Cancer Discov,2011,1(7):587-597.
• [8]Hisaoka M,Matsuyama A,Nakamoto M.Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma[J].Am J Pathol,2012,180(5):2076-2083.
• [9]Lee DH,Amanat S,Goff C,et al.Abstract 4203:overexpression of mi R-26a-2 in human liposarcoma is correlated with poor patient survival[J].Oncogenesis,2013,2(5):47.
• [10]Gie?la M,Dulak J,Józkowicz A.Micro RNAs and epigenetic mechanisms of rhabdomyosarcoma,development[J].Int J Biochem Cell Biol,2014,53(8):482-492.
• [11]Novák J,Vinklárek J,Ondex J,et al.Micro RNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis[J].Pediatr Blood Cancer,2013,60(11):1739-1746.
• [12]Missiaglia E,Shepherd CJ,Patel S,et al.Micro RNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas[J].Br J Cancer,2010,102(12):1769-1777.
• [13]Rota R,Ciarapica R,Giordano A,et al.Micro RNAs in rhabdomyosarcoma:pathogenetic implications and translational potentiality[J].Molecular Cancer,2011,10(27):2140-2145.
• [14]Chen CF,He XL,Arslan AD,et al.Novel regulation of nuclear factor-YB by mi R-485-3p affects the expression of DNA topoisomerase IIαand drug responsiveness[J].Molecular Pharmacol,2011,79(4):735-741.
• [15]Wakamatsu T,Naka N,Sasagawa S,et al.Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor-and chemokine(C-X-C motif)receptor 4-targeted therapy in synovial sarcoma[J].Cancer Sci,2014,105(9):1124-1134.
• [16]Kubo T,Shimose S,Fujimori J,et al.Prognostic value of SS18-ssx of SS184-targeted therapy in synovial sarcoma:systematic review and meta-analysis[J].Springerplus,2015,4(1):1-7.
• [17]Tamaki S,Fukuta M,Sekiguchi K,et al.SS18-SSX,the oncogenic fusion protein in synovial sarcoma,is a cellular context-dependent epigenetic modifier[J].Plos One,2015,10(11):e0142991.
• [18]Minami Y,Kohsaka S,Tsuda M,et al.SS18-SSX-regulated mi R-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1[J].Cancer Sci,2014,105(9):1152-1159.
• [19]Subramanian S,Thayanithy V,West RB,et al.Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of mi R-34a expression in malignant peripheral nerve sheath tumours[J].Experientia,2010,220(1):58-70.
• [20]Itani S,Kunisada T,Morimoto Y,et al.Micro RNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor(MPNST)via programmed cell death protein 4(PDCD4)[J].J Cancer Res Clin Oncol,2012,138(9):1501-1509.
• [21]Presneau N,Eskandarpour M,Shemais T,et al.Micro RNA profiling of peripheral nerve sheath tumours identifies mi R-29c as a tumour suppressor gene involved in tumour progression[J].Br J Cancer,2013,108(4):964-972.
• [22]Zhang P,Garnett J,Creighton CJ,et al.EZH2-mi R-30d-KPNB1pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis[J].J Pathol,2014,232(3):308-318.
• [23]Italiano A,Thomas R,Breen M,et al.The mi R cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification[J].Genes Chromosomes Cancer,2012,51(6):569-578.
• [24]Liu P,Wilson MJ.mi R-520c and mi R-373 upregulate MMP9 expression by targeting m TOR and SIRT1,and activate the Ras/Raf/MEK/Erk signaling pathway and NF-k B factor[J].J Cellular Physiol,2012,227(2):867-876.
• [25]Weng C,Dong H,Chen G,et al.mi R-409-3p inhibits HT1080 cell proliferation,vascularization and metastasis by targeting angiogenin[J].Cancer Lett,2012,323(2):171-179.
• [26]Papp G,Krausz T,Stricker TP,et al.SMARCB1,expression in epithelioid sarcoma is regulated by mi R-206,mi R-381,and mi R-671-5p on both m RNA and protein levels[J].Genes Chromosomes Cancer,2014,53(2):168-176.
• [27]Cantara S,Pilli T,Sebastiani G,et al.Circulating mi RNA95 and mi RNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population[J].J Clin EndocrinolMetabolism,2014,99(11):4190-4198.
• [28]Duroux-Richard I,Pers YM,Fabre S,et al.Circulating mi RNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis[J].Mediators Inflammation,2014,2014(23):342524.
• [29]El-Abd NE,Fawzy NA,El-Sheikh SM,et al.Circulating mi RNA-122,mi RNA-199a,and mi RNA-16 as biomarkers for early detection of hepatocellular carcinoma in egyptian patients with chronic hepatitis C virus infection[J].Molecular Diagnosis Ther,2015,19(4):213-220.
• [30]Fujiwara T.Circulating Micro RNAs in sarcoma:potential biomarkers for diagnosis and targets for therapy[J].2014,3(123):2.
• [31]Miyachi M,Tsuchiya KH,Yagyu S,et al.Circulating muscle-specific micro RNA,mi R-206,as a potential diagnostic marker for rhabdomyosarcoma[J].Biochem Biophysical Res Comm,2010,400(1):89-93.
• [32]Weng Y,Chen Y,Chen J,et al.Identification of serum micro RNAs in genome-wide serum micro RNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis[J].Med Oncol,2013,30(2):1-6.